Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Remmie Health has launched FDA-registered digital otoscopes (Remmie 3 and 4) for at-home ear, nose, and throat imaging, which can be shared with providers via telemedicine. Its AI platform (Remmie.ai) is in research and early clinical validation to support remote ENT diagnosis, supported by NIH SBIR grants. Commercial sales began in October 2023, and major provider partnerships are in place. AI clinical validation is ongoing in collaboration with national children’s hospitals and pediatric centers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Remmie Health.